nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—F2—Common Pathway—F13B—age related macular degeneration	0.0346	0.0443	CbGpPWpGaD
Captopril—MMP2—Matrix Metalloproteinases—TIMP3—age related macular degeneration	0.0344	0.044	CbGpPWpGaD
Captopril—F2—Blood Clotting Cascade—F13B—age related macular degeneration	0.0295	0.0377	CbGpPWpGaD
Captopril—F2—Intrinsic Pathway—SERPING1—age related macular degeneration	0.0277	0.0355	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—TIMP3—age related macular degeneration	0.027	0.0345	CbGpPWpGaD
Captopril—LTA4H—eye—age related macular degeneration	0.0248	0.113	CbGeAlD
Captopril—LTA4H—retina—age related macular degeneration	0.0246	0.112	CbGeAlD
Captopril—LTA4H—connective tissue—age related macular degeneration	0.0239	0.109	CbGeAlD
Captopril—MMP9—Matrix Metalloproteinases—TIMP3—age related macular degeneration	0.0226	0.0289	CbGpPWpGaD
Captopril—F2—Formation of Fibrin Clot (Clotting Cascade)—F13B—age related macular degeneration	0.0199	0.0254	CbGpPWpGaD
Captopril—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPING1—age related macular degeneration	0.0187	0.0239	CbGpPWpGaD
Captopril—REN—connective tissue—age related macular degeneration	0.0184	0.0843	CbGeAlD
Captopril—MMP2—eye—age related macular degeneration	0.0176	0.0804	CbGeAlD
Captopril—MMP2—retina—age related macular degeneration	0.0174	0.0797	CbGeAlD
Captopril—MMP9—Assembly of collagen fibrils and other multimeric structures—COL8A1—age related macular degeneration	0.0171	0.0219	CbGpPWpGaD
Captopril—MMP2—connective tissue—age related macular degeneration	0.017	0.0775	CbGeAlD
Captopril—MMP9—eye—age related macular degeneration	0.0153	0.0699	CbGeAlD
Captopril—MMP9—connective tissue—age related macular degeneration	0.0147	0.0674	CbGeAlD
Captopril—MMP9—Assembly of collagen fibrils and other multimeric structures—COL10A1—age related macular degeneration	0.0145	0.0186	CbGpPWpGaD
Captopril—MMP2—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.0144	0.0184	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—F13B—age related macular degeneration	0.0134	0.0171	CbGpPWpGaD
Captopril—F2—eye—age related macular degeneration	0.0134	0.061	CbGeAlD
Captopril—F2—connective tissue—age related macular degeneration	0.0129	0.0588	CbGeAlD
Captopril—F2—Complement and Coagulation Cascades—SERPING1—age related macular degeneration	0.0126	0.0161	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—C9—age related macular degeneration	0.0126	0.0161	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—COL10A1—age related macular degeneration	0.0123	0.0158	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—TIMP3—age related macular degeneration	0.0123	0.0158	CbGpPWpGaD
Captopril—MMP9—Collagen formation—COL8A1—age related macular degeneration	0.0116	0.0149	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—CFI—age related macular degeneration	0.0109	0.014	CbGpPWpGaD
Captopril—MMP9—Collagen formation—COL10A1—age related macular degeneration	0.0099	0.0127	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00985	0.0126	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—ADAMTS9—age related macular degeneration	0.00945	0.0121	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—C2—age related macular degeneration	0.00904	0.0116	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00882	0.0113	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00882	0.0113	CbGpPWpGaD
Captopril—ACE—eye—age related macular degeneration	0.00816	0.0373	CbGeAlD
Captopril—ACE—connective tissue—age related macular degeneration	0.00786	0.0359	CbGeAlD
Captopril—MMP2—Direct p53 effectors—TNFRSF10A—age related macular degeneration	0.0076	0.00973	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—CFH—age related macular degeneration	0.00756	0.00968	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—CFB—age related macular degeneration	0.00733	0.00939	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—COL8A1—age related macular degeneration	0.0071	0.00909	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—KDR—age related macular degeneration	0.00692	0.00886	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00677	0.00867	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00677	0.00867	CbGpPWpGaD
Captopril—F2—Cell surface interactions at the vascular wall—SLC16A8—age related macular degeneration	0.0067	0.00858	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—age related macular degeneration	0.0064	0.00819	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00604	0.00773	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00604	0.00773	CbGpPWpGaD
Captopril—ALB—HDL-mediated lipid transport—CETP—age related macular degeneration	0.00594	0.00761	CbGpPWpGaD
Captopril—MMP9—IL1 and megakaryotyces in obesity—CCL2—age related macular degeneration	0.00594	0.0076	CbGpPWpGaD
Captopril—ABCB1—ABC-family proteins mediated transport—ABCG4—age related macular degeneration	0.00587	0.00752	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00568	0.00727	CbGpPWpGaD
Captopril—ABCB1—ABC-family proteins mediated transport—ABCA4—age related macular degeneration	0.00523	0.0067	CbGpPWpGaD
Captopril—CYP2D6—Melatonin metabolism and effects—MAP2—age related macular degeneration	0.00523	0.00669	CbGpPWpGaD
Captopril—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC16A8—age related macular degeneration	0.0052	0.00666	CbGpPWpGaD
Captopril—LTA4H—Metabolism—NMNAT1—age related macular degeneration	0.00502	0.00642	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—B3GLCT—age related macular degeneration	0.00467	0.00598	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—COL8A1—age related macular degeneration	0.00466	0.00596	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—CCL2—age related macular degeneration	0.00458	0.00587	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—FBLN5—age related macular degeneration	0.00444	0.00569	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—EFEMP1—age related macular degeneration	0.00444	0.00569	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ELOVL4—age related macular degeneration	0.00438	0.00561	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00438	0.00561	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00438	0.00561	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00437	0.0056	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—age related macular degeneration	0.0042	0.00538	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00406	0.0052	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—ADAMTS9—age related macular degeneration	0.00396	0.00507	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—COL10A1—age related macular degeneration	0.00396	0.00507	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00394	0.00504	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00394	0.00504	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.00392	0.00502	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—SERPING1—age related macular degeneration	0.00391	0.00501	CbGpPWpGaD
Captopril—MMP9—Angiogenesis—VEGFA—age related macular degeneration	0.00381	0.00488	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—CCL2—age related macular degeneration	0.00379	0.00486	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—SERPING1—age related macular degeneration	0.00373	0.00477	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—KDR—age related macular degeneration	0.00354	0.00453	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—LIPC—age related macular degeneration	0.00354	0.00453	CbGpPWpGaD
Captopril—LTA4H—Metabolism—SLC16A8—age related macular degeneration	0.00353	0.00452	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—CETP—age related macular degeneration	0.00341	0.00437	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00318	0.00408	CbGpPWpGaD
Captopril—ALB—HDL-mediated lipid transport—APOE—age related macular degeneration	0.00315	0.00403	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00305	0.0039	CbGpPWpGaD
Captopril—F2—Post-translational protein modification—ADAMTS9—age related macular degeneration	0.00301	0.00386	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00298	0.00382	CbGpPWpGaD
Captopril—F2—Complement and Coagulation Cascades—C3—age related macular degeneration	0.00285	0.00365	CbGpPWpGaD
Captopril—ABCB1—retina—age related macular degeneration	0.00285	0.013	CbGeAlD
Captopril—MMP2—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00282	0.00361	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00254	0.00325	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CCL2—age related macular degeneration	0.00252	0.00323	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.00251	0.00321	CbGpPWpGaD
Captopril—F2—Folate Metabolism—CRP—age related macular degeneration	0.00248	0.00318	CbGpPWpGaD
Captopril—F2—Hemostasis—F13B—age related macular degeneration	0.0024	0.00307	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00236	0.00303	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00236	0.00302	CbGpPWpGaD
Captopril—ALB—Lipid and lipoprotein metabolism—LIPC—age related macular degeneration	0.00235	0.00301	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—RHO—age related macular degeneration	0.00232	0.00297	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—KDR—age related macular degeneration	0.00232	0.00297	CbGpPWpGaD
Captopril—ALB—Lipid and lipoprotein metabolism—CETP—age related macular degeneration	0.00227	0.0029	CbGpPWpGaD
Captopril—F2—Hemostasis—SERPING1—age related macular degeneration	0.00225	0.00289	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—SKIV2L—age related macular degeneration	0.00222	0.00284	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—B3GLCT—age related macular degeneration	0.00222	0.00284	CbGpPWpGaD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00208	0.00266	CbGpPWpGaD
Captopril—F2—Folate Metabolism—CCL2—age related macular degeneration	0.00204	0.00261	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—CRP—age related macular degeneration	0.00197	0.00252	CbGpPWpGaD
Captopril—F2—Hemostasis—RAD51B—age related macular degeneration	0.00195	0.0025	CbGpPWpGaD
Captopril—MMP2—EPH-Ephrin signaling—VEGFA—age related macular degeneration	0.00195	0.0025	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TLR4—age related macular degeneration	0.00194	0.00248	CbGpPWpGaD
Captopril—F2—Hemostasis—SLC16A8—age related macular degeneration	0.00182	0.00233	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00181	0.00232	CbGpPWpGaD
Captopril—ALB—Lipoprotein metabolism—APOE—age related macular degeneration	0.00181	0.00232	CbGpPWpGaD
Captopril—LTA4H—Metabolism—LIPC—age related macular degeneration	0.00181	0.00232	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—RHO—age related macular degeneration	0.00177	0.00226	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CETP—age related macular degeneration	0.00175	0.00223	CbGpPWpGaD
Captopril—MMP9—Endochondral Ossification—VEGFA—age related macular degeneration	0.00174	0.00223	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—SERPING1—age related macular degeneration	0.00174	0.00222	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CCL2—age related macular degeneration	0.00166	0.00213	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.00162	0.00208	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.00162	0.00207	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.00162	0.00207	CbGpPWpGaD
Captopril—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—age related macular degeneration	0.0016	0.00205	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—KDR—age related macular degeneration	0.00155	0.00198	CbGpPWpGaD
Captopril—CYP2D6—Melatonin metabolism and effects—APOE—age related macular degeneration	0.00154	0.00197	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ADAMTS9—age related macular degeneration	0.00143	0.00183	CbGpPWpGaD
Captopril—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—age related macular degeneration	0.00141	0.0018	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.00135	0.00172	CbGpPWpGaD
Captopril—MMP2—Axon guidance—KDR—age related macular degeneration	0.00131	0.00168	CbGpPWpGaD
Captopril—MMP9—EPH-Ephrin signaling—VEGFA—age related macular degeneration	0.00128	0.00164	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CCL2—age related macular degeneration	0.00125	0.0016	CbGpPWpGaD
Captopril—ALB—SLC-mediated transmembrane transport—SLC16A8—age related macular degeneration	0.00123	0.00157	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—CRP—age related macular degeneration	0.00121	0.00155	CbGpPWpGaD
Captopril—ALB—Lipid and lipoprotein metabolism—APOE—age related macular degeneration	0.0012	0.00154	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.0012	0.00154	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.0012	0.00154	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—APOE—age related macular degeneration	0.00118	0.00152	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RDH8—age related macular degeneration	0.00113	0.00145	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—C3—age related macular degeneration	0.00112	0.00143	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CD36—age related macular degeneration	0.00109	0.00139	CbGpPWpGaD
Captopril—LTA4H—Metabolism—CD36—age related macular degeneration	0.00105	0.00134	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.00105	0.00134	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—KDR—age related macular degeneration	0.00102	0.0013	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—RHO—age related macular degeneration	0.000999	0.00128	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—CCL2—age related macular degeneration	0.000995	0.00127	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RPE65—age related macular degeneration	0.00099	0.00127	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—CRP—age related macular degeneration	0.000984	0.00126	CbGpPWpGaD
Captopril—ALB—Hemostasis—F13B—age related macular degeneration	0.000951	0.00122	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—KDR—age related macular degeneration	0.000938	0.0012	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—CD36—age related macular degeneration	0.000936	0.0012	CbGpPWpGaD
Captopril—LTA4H—Metabolism—APOE—age related macular degeneration	0.000926	0.00118	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—RHO—age related macular degeneration	0.000907	0.00116	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPING1—age related macular degeneration	0.000895	0.00115	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—CD36—age related macular degeneration	0.000892	0.00114	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCL2—age related macular degeneration	0.000876	0.00112	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RDH8—age related macular degeneration	0.000874	0.00112	CbGpPWpGaD
Captopril—MMP9—Axon guidance—KDR—age related macular degeneration	0.000863	0.0011	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000814	0.00104	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—CCL2—age related macular degeneration	0.00081	0.00104	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000799	0.00102	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ABCA4—age related macular degeneration	0.000798	0.00102	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—C3—age related macular degeneration	0.000785	0.00101	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CRP—age related macular degeneration	0.000782	0.001	CbGpPWpGaD
Captopril—ALB—Hemostasis—RAD51B—age related macular degeneration	0.000776	0.000993	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RPE65—age related macular degeneration	0.000764	0.000978	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—C3—age related macular degeneration	0.000751	0.000961	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—age related macular degeneration	0.000749	0.000959	CbGpPWpGaD
Captopril—MMP2—Axon guidance—VEGFA—age related macular degeneration	0.000724	0.000927	CbGpPWpGaD
Captopril—ALB—Hemostasis—SLC16A8—age related macular degeneration	0.000721	0.000923	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CD36—age related macular degeneration	0.000712	0.000912	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.0007	0.000897	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—RHO—age related macular degeneration	0.000694	0.000889	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFBR1—age related macular degeneration	0.000673	0.000861	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—CCL2—age related macular degeneration	0.000643	0.000823	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000624	0.000799	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000624	0.000799	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CCL2—age related macular degeneration	0.000621	0.000795	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ABCA4—age related macular degeneration	0.000616	0.000789	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—KDR—age related macular degeneration	0.000616	0.000788	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCG4—age related macular degeneration	0.000614	0.000786	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000593	0.000759	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL2—age related macular degeneration	0.000587	0.000752	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—C3—age related macular degeneration	0.000572	0.000732	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CCL2—age related macular degeneration	0.000559	0.000715	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—SLC16A8—age related macular degeneration	0.000547	0.0007	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ABCA4—age related macular degeneration	0.000547	0.0007	CbGpPWpGaD
Captopril—F2—Hemostasis—CD36—age related macular degeneration	0.000539	0.000691	CbGpPWpGaD
Captopril—F2—Signaling Pathways—RHO—age related macular degeneration	0.000536	0.000686	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—VEGFA—age related macular degeneration	0.000517	0.000662	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000498	0.000638	CbGpPWpGaD
Captopril—MMP9—Axon guidance—VEGFA—age related macular degeneration	0.000475	0.000608	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—age related macular degeneration	0.000456	0.000583	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL2—age related macular degeneration	0.000447	0.000573	CbGpPWpGaD
Captopril—ALB—Platelet degranulation—VEGFA—age related macular degeneration	0.000446	0.000571	CbGpPWpGaD
Captopril—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—age related macular degeneration	0.000425	0.000544	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—CD36—age related macular degeneration	0.000415	0.000532	CbGpPWpGaD
Captopril—ALB—Metabolism—NMNAT1—age related macular degeneration	0.000415	0.000531	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—VEGFA—age related macular degeneration	0.000394	0.000505	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TGFBR1—age related macular degeneration	0.00039	0.000499	CbGpPWpGaD
Captopril—ABCB1—Metabolism—NMNAT1—age related macular degeneration	0.000364	0.000465	CbGpPWpGaD
Captopril—ALB—Metabolism—ELOVL4—age related macular degeneration	0.000363	0.000464	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—SQSTM1—age related macular degeneration	0.000353	0.000452	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000343	0.000439	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—VEGFA—age related macular degeneration	0.000339	0.000434	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000336	0.00043	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000324	0.000415	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—C3—age related macular degeneration	0.000323	0.000414	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ELOVL4—age related macular degeneration	0.000318	0.000407	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—CCL2—age related macular degeneration	0.000315	0.000403	CbGpPWpGaD
Captopril—ALB—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.000308	0.000395	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000301	0.000385	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000299	0.000383	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—C3—age related macular degeneration	0.000293	0.000376	CbGpPWpGaD
Captopril—ALB—Metabolism—SLC16A8—age related macular degeneration	0.000292	0.000374	CbGpPWpGaD
Captopril—F2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000273	0.000349	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—CETP—age related macular degeneration	0.00027	0.000346	CbGpPWpGaD
Captopril—F2—Hemostasis—VEGFA—age related macular degeneration	0.000257	0.000329	CbGpPWpGaD
Captopril—ABCB1—Metabolism—SLC16A8—age related macular degeneration	0.000256	0.000328	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000241	0.000309	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL2—age related macular degeneration	0.00023	0.000294	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—C3—age related macular degeneration	0.000224	0.000287	CbGpPWpGaD
Captopril—ALB—Hemostasis—CD36—age related macular degeneration	0.000214	0.000274	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—APOE—age related macular degeneration	0.000209	0.000267	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—KDR—age related macular degeneration	0.000205	0.000262	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—VEGFA—age related macular degeneration	0.000198	0.000253	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000195	0.000249	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—age related macular degeneration	0.000195	0.000249	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL2—age related macular degeneration	0.000176	0.000225	CbGpPWpGaD
Captopril—F2—Signaling Pathways—C3—age related macular degeneration	0.000173	0.000222	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000172	0.00022	CbGpPWpGaD
Captopril—F2—Signaling Pathways—APOE—age related macular degeneration	0.000161	0.000207	CbGpPWpGaD
Captopril—F2—Signaling Pathways—KDR—age related macular degeneration	0.000158	0.000202	CbGpPWpGaD
Captopril—ALB—Metabolism—LIPC—age related macular degeneration	0.00015	0.000192	CbGpPWpGaD
Captopril—ALB—Metabolism—CETP—age related macular degeneration	0.000144	0.000185	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL2—age related macular degeneration	0.000136	0.000174	CbGpPWpGaD
Captopril—ABCB1—Metabolism—LIPC—age related macular degeneration	0.000131	0.000168	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CETP—age related macular degeneration	0.000127	0.000162	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000124	0.000158	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000119	0.000153	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—VEGFA—age related macular degeneration	0.000113	0.000144	CbGpPWpGaD
Captopril—ALB—Hemostasis—VEGFA—age related macular degeneration	0.000102	0.00013	CbGpPWpGaD
Captopril—F2—Signaling Pathways—VEGFA—age related macular degeneration	8.71e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Metabolism—CD36—age related macular degeneration	8.68e-05	0.000111	CbGpPWpGaD
Captopril—ALB—Metabolism—APOE—age related macular degeneration	7.66e-05	9.8e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CD36—age related macular degeneration	7.6e-05	9.73e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CD36—age related macular degeneration	7.16e-05	9.17e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—APOE—age related macular degeneration	6.71e-05	8.59e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—APOE—age related macular degeneration	6.32e-05	8.09e-05	CbGpPWpGaD
